Synapse - Gregory Riely

Results (219)

Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers

Journal Article

Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
Cancer (2019)

Fulltext@MSK | Save

Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: Comparison with standard histopathologic approach

Journal Article

Chang, J. C.; Alex, D.; Bott, M.; Tan, K. S.; Seshan, V.; Golden, A.; Sauter, J. L.; Buonocore, D. J.; Vanderbilt, C. M.; Gupta, S.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

A novel activating MAP2K1 in-frame deletion mediates acquired resistance to ROS1 TKIs in a patient with ROS1 fusion-positive NSCLC

Meeting Abstract

Sato, H.; Schoenfeld, A.; Siau, E.; Suzawa, K.; Yue, C.; Offin, M.; Drilon, A.; Davare, M.; Riely, G.; Ladanyi, M.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Tissue-based molecular and histologic landscape of acquired resistance to osimertinib in patients with EGFR-mutant lung cancers

Meeting Abstract

Schoenfeld, A.; Chan, J.; Rizvi, H.; Somwar, R.; Kubota, D.; Daneshbod, Y.; Chang, J.; Offin, M.; Arcila, M.; Pe'Er, D.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers

Meeting Abstract

Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
Journal of Thoracic Oncology (2019)

Fulltext@MSK | Save

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Journal Article

Hastings, K.; Yu, H. A.; Wei, W.; Sanchez-Vega, F.; DeVeaux, M.; Choi, J.; Rizvi, H.; Lisberg, A.; Truini, A.; Lydon, C. A.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers

Journal Article

Mondaca, S.; Offin, M.; Borsu, L.; Myers, M.; Josyula, S.; Makhnin, A.; Shen, R.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; more...
Acta Oncologica (2019)

Fulltext@MSK | Save

Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers

Meeting Abstract

Schoenfeld, A. J.; Chan, J. M.; Rizvi, H.; Rekhtman, N.; Daneshbod, Y.; Kubota, D.; Chang, J. C.; Arcila, M. E.; Ladanyi, M.; Somwar, R.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes